#1 Clinical Trials Search in Europe

Caspofungin Acetate

Caspofungin Acetate, also known as MK0991 or Cancidas®, is an antifungal medication being studied in various clinical trials. These trials aim to evaluate its safety, efficacy, and appropriate dosing for treating different types of fungal infections, particularly in vulnerable populations such as children, neonates, and immunocompromised patients. The drug is being investigated for conditions like invasive candidiasis, esophageal candidiasis, and aspergillosis, as well as for empirical therapy in patients with persistent fever and neutropenia.

Table of Contents

What is Caspofungin Acetate?

Caspofungin acetate is an antifungal medication used to treat various types of fungal infections. It is also known by its brand name Cancidas® or by its research code MK0991[1][2]. This medication works by preventing the growth of fungi in the body, making it an important tool in fighting serious fungal infections, especially in people with weakened immune systems.

What Conditions Does Caspofungin Treat?

Caspofungin acetate is used to treat several types of fungal infections, including:

  • Invasive Candidiasis: This is a serious infection caused by Candida fungi that can affect the blood, heart, brain, eyes, bones, and other parts of the body[1][5].
  • Esophageal Candidiasis: A fungal infection of the esophagus (the tube that connects the throat to the stomach)[1].
  • Aspergillosis: A type of fungal infection caused by Aspergillus mold, which can be particularly dangerous for people with weakened immune systems[6][9].
  • Fungal infections in patients with fever and neutropenia: Neutropenia is a condition where there are abnormally low levels of neutrophils, a type of white blood cell important for fighting infections[4].

How is Caspofungin Administered?

Caspofungin acetate is given as an intravenous (IV) infusion, which means it’s delivered directly into the bloodstream through a vein. The infusion typically takes about 1-2 hours to complete[1][8]. The medication is usually administered once daily, and the duration of treatment can vary depending on the type and severity of the infection.

Dosage Information

The dosage of caspofungin can vary based on the specific condition being treated and the patient’s characteristics. However, some common dosing regimens include:

  • A loading dose of 70 mg on the first day, followed by 50 mg daily for subsequent days[1][8].
  • For some conditions, a higher dose of 150 mg daily may be used[8].
  • In children, the dose is often calculated based on body surface area, typically 50 mg/m² daily[2].

The duration of treatment can range from a minimum of 7 days to several weeks or even months, depending on the type and severity of the infection and the patient’s response to treatment[1][8].

Efficacy of Caspofungin

Clinical trials have shown that caspofungin is effective in treating various fungal infections. For example:

  • In patients with invasive candidiasis, a significant proportion of patients showed a favorable response to caspofungin treatment[1].
  • Caspofungin has also shown efficacy in treating aspergillosis in patients with hematologic (blood) cancers or those who have undergone stem cell transplants[9].

Safety and Side Effects

While caspofungin is generally well-tolerated, like all medications, it can cause side effects. Common side effects may include:

  • Fever
  • Nausea
  • Vomiting
  • Diarrhea
  • Headache
  • Skin rash

More serious side effects are rare but can occur. These may include severe allergic reactions or liver problems. It’s important to report any unusual symptoms to your healthcare provider[1][8].

Use in Special Populations

Caspofungin has been studied in various patient groups:

  • Children: Studies have been conducted to determine the appropriate dosing and safety of caspofungin in children, including infants and neonates (newborns)[2][3].
  • Immunocompromised patients: Caspofungin is often used in patients with weakened immune systems, such as those undergoing chemotherapy or stem cell transplantation[4][9].
  • Critically ill patients: Research has been conducted on the use of caspofungin in critically ill patients who are at high risk for developing invasive fungal infections[5].

Ongoing Research

Researchers continue to study caspofungin to optimize its use and explore new applications. Some areas of ongoing research include:

  • Comparing different dosing regimens to find the most effective and safe approach[8].
  • Investigating the use of caspofungin as a preventive treatment (prophylaxis) in high-risk patients[5].
  • Studying the effectiveness of caspofungin compared to other antifungal treatments[10].

As research continues, our understanding of how to best use caspofungin to treat and prevent fungal infections will continue to improve, potentially leading to better outcomes for patients.

Aspect Details
Drug Name Caspofungin Acetate (MK0991, Cancidas®)
Primary Conditions Studied Invasive Candidiasis, Esophageal Candidiasis, Aspergillosis, Fungal Infections in Febrile Neutropenia
Patient Populations Adults, Children (including neonates and infants), Immunocompromised patients
Administration Method Intravenous (IV)
Typical Treatment Duration 4-90 days (varies by condition and study)
Primary Outcomes Measured Safety, Efficacy, Pharmacokinetics
Key Safety Assessments Drug-related adverse events, Serious adverse events, Discontinuations due to adverse events
Key Efficacy Assessments Favorable overall response, Clinical improvement, Microbiological eradication

FAQ

  • What is Caspofungin Acetate used for? Caspofungin Acetate is an antifungal medication used to treat various fungal infections, including invasive candidiasis, esophageal candidiasis, and aspergillosis. It's also being studied for use in patients with persistent fever and neutropenia.
  • How is Caspofungin Acetate administered? Caspofungin Acetate is typically administered intravenously (IV). The dosage and duration of treatment vary depending on the specific condition being treated and the patient's age and weight.
  • Are there any clinical trials studying Caspofungin Acetate in children? Yes, several clinical trials are investigating the use of Caspofungin Acetate in children, including neonates and infants. These studies aim to determine appropriate dosing, safety, and efficacy in pediatric populations.
  • What are the main outcomes being measured in Caspofungin Acetate trials? The main outcomes being measured include safety (such as the occurrence of drug-related adverse events), efficacy (such as favorable response rates to treatment), and pharmacokinetics (how the drug moves through the body, especially in different patient populations).
  • How long do treatments with Caspofungin Acetate typically last in clinical trials? The duration of treatment varies depending on the specific condition and trial design. In the studies mentioned, treatment durations ranged from a minimum of 4 days to a maximum of 90 days, with many trials treating patients for 14-28 days.

Ongoing Clinical Trials on Caspofungin Acetate

  • Study of fosmanogepix compared to standard antifungal drugs for treating invasive mold infections in adults

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium France Germany Greece Italy +2

  • Shortening treatment duration in adults with uncomplicated candidemia: caspofungin acetate versus saline and sodium lactate placebo

    Not yet recruiting

    1 1 1
    Investigated drugs:
    Germany

  • Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium Bulgaria France Germany Greece Italy +1

Glossary

  • Candidiasis: An infection caused by Candida fungi, which can affect various parts of the body including the bloodstream, esophagus, and other organs.
  • Aspergillosis: A fungal infection caused by Aspergillus mold, which primarily affects the lungs but can spread to other parts of the body in severe cases.
  • Neutropenia: A condition characterized by an abnormally low count of neutrophils, a type of white blood cell important for fighting infections.
  • Empirical therapy: Treatment based on clinical experience in the absence of complete information, often used when an infection is suspected but not yet confirmed.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Intravenous (IV): A method of administering medication directly into a vein.
  • Adverse event: Any unfavorable and unintended sign, symptom, or disease associated with the use of a medical treatment.
  • Efficacy: The ability of a treatment to produce a desired or intended result.
  • Immunocompromised: Having a weakened immune system, which increases susceptibility to infections.
  • Hematopoietic stem cell transplantation (HSCT): A procedure that replaces damaged or diseased bone marrow with healthy stem cells, often used in treating blood cancers and other disorders.

References

  1. https://clinicaltrials.gov/study/NCT00635648
  2. https://clinicaltrials.gov/study/NCT00292071
  3. https://clinicaltrials.gov/study/NCT00330395
  4. https://clinicaltrials.gov/study/NCT00379964
  5. https://clinicaltrials.gov/study/NCT01045798
  6. https://clinicaltrials.gov/study/NCT00082524
  7. https://clinicaltrials.gov/study/NCT00020527
  8. https://clinicaltrials.gov/study/NCT00250432
  9. https://clinicaltrials.gov/study/NCT00110045
  10. https://clinicaltrials.gov/study/NCT01288378